Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study

BACKGROUND: ‘No evidence of disease activity’ (NEDA), a composite measure of clinical and magnetic resonance imaging outcomes, provides a comprehensive assessment of disease activity, but is not extensively reported in clinical practice. NEDA-3 is defined as patients with no new/enlarged T2 or gadol...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinstock-Guttman, Bianca, Medin, Jennie, Khan, Nasreen, Korn, Jonathan R., Lathi, Ellen, Silversteen, Jason, Calkwood, Jonathan, Silva, Diego, Zivadinov, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843701/
https://www.ncbi.nlm.nih.gov/pubmed/29270772
http://dx.doi.org/10.1007/s40263-017-0482-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843701/
https://www.ncbi.nlm.nih.gov/pubmed/29270772
http://dx.doi.org/10.1007/s40263-017-0482-4

Ejemplares similares